Undisclosed payments by pharmaceutical manufacturers to authors of inflammatory bowel disease guidelines in the United States

Background: Payments from pharmaceutical drug manufacturers to authors of clinical practice guidelines (CPGs) may have an impact on their recommendations. In this study, we aimed to evaluate the accuracy of financial conflict of interest (FCOI) declarations among authors of Inflammatory Bowel Diseas...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Eman Al Sulais, Majid Alsahafi, Turki AlAmeel
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wolters Kluwer Medknow Publications 2021-01-01
Reeks:	The Saudi Journal of Gastroenterology
Onderwerpen:	conflict of interest financial declaration guidelines inflammatory bowel disease
Online toegang:	http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2021;volume=27;issue=6;spage=342;epage=347;aulast=Al
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!